Filter Specialty

Submit to journal

Submit To The Journals

Adjuvant Ado-trastuzumab Emtansine Reduces the Risk of Recurrence Compared to Trastuzumab in Early-stage HER2-positive Breast Cancer

Breast Cancer

Adjuvant Ado-trastuzumab Emtansine Reduces the Risk of Recurrence Compared to Trastuzumab in Early-stage HER2-positive Breast Cancer

Katrina Mountfort
Senior Medical Writer, Touch Medical Media, UK

Liquid Biopsies to Predict Therapeutic Response – The SOLAR-1 Study

Breast Cancer

Liquid Biopsies to Predict Therapeutic Response – The SOLAR-1 Study

Katrina Mountfort
Senior Medical Writer, Touch Medical Media, UK

oncology Article

Gaucher Disease for the Haematologist

Maria-Domenica Cappellini

European Oncology & Haematology. 2019;15(1):Epub ahead of print
$Tisagenlecleucel in Paediatric and Young Adult Patients with Relapsed and Refractory Acute Lymphoblastic Leukaemia: New Data from the ELIANA Study$
Haematological Malignancies

Tisagenlecleucel in Paediatric and Young Adult Patients with Relapsed and Refractory Acute Lymphoblastic Leukaemia: New Data from the ELIANA Study

Katrina Mountfort
Senior Medical Writer, Touch Medical Media, UK
Diagnostics and Screening

Large-scale Genomic Testing Facilitates Precision Medicine in Routine Cancer Care

Ricardo H Álvarez

Oncology & Hematology Review, 2018;15(1):Epub ahead of print
Haematology

András Illés, ESMO 2018 – A New Biosimilar for the Treatment of Chemotherapy-induced Neutropenia
oncology Article

Foreword – European Oncology & Haematology. 2018;14(2):75

Axel S Merseburger

European Oncology & Haematology. 2018;14(2):75
Haematology

Maria Domenica Cappellini, ASH 2018 – Gaucher Disease for the Haematologist
Genitourinary Cancers

Targeted Alpha Therapy – Optimising Survival in Advanced Prostate Cancer

Johann S De Bono

European Oncology & Haematology. 2018;14(Suppl 3);3–10
$Optimising Treatment in Relapsed, Refractory Multiple Myeloma$
Haematological Malignancies

Optimising Treatment in Relapsed, Refractory Multiple Myeloma

Monique Minnema, Maria Gavriatopoulou

European Oncology & Haematology. 2018;14(2):96–104 DOI: https://doi.org/10.17925/EOH.2018.14.2.96
Haematological Malignancies

Robin Foà, ASH 2018 – Developments in the Treatment of Haematological Malignancies
Haematology

Shaping Macrophage Plasticity with Iron – Towards a New Therapeutic Approach

Francesca Vinchi

European Oncology & Haematology. 2018;14(2):76–7 DOI: https://doi.org/10.17925/EOH.2018.14.2.76
Haematology

Centrifugal and Membrane Therapeutic Plasma Exchange – A Mini-review

Michiel Etienne Janssens, Stuart Wakelin

European Oncology & Haematology, 2018;14(2):105–9 DOI: https://doi.org/10.17925/EOH.2018.14.2.105
Lung Cancer

Treatment Resistant de novo Epidermal Growth Factor Receptor (EGFR)-mutated Small Cell Lung Cancer

Branka Petricevic, Rebecca Y Tay, Raffaele Califano

European Oncology & Hematology Review. 2018;14(2):84–6 DOI: https://doi.org/10.17925/EOH.2018.14.2.84
Prostate Cancer

Proton Beam Therapy

Jason Lester

European Oncology & Haematology, 2018;14(2):82–3 DOI: https://doi.org/10.17925/EOH.2018.14.2.82
oncology Article

Lenvatinib in Hepatocellular Carcinoma

Miguel Marcao

European Oncology & Haematology, 2018;14(2):80–1 DOI: https://doi.org/10.17925/EOH.2018.14.2.80
Dermatological Cancer

BRAF-mutant Melanoma – The COLUMBUS Trial

Reinhard Dummer

European Oncology & Haematology. 2018;14(2):78–9 DOI: https://doi.org/10.17925/EOH.2018.14.2.78

Load More Posts

Videos

As well as peer-reviewed journals, touchONCOLOGY also provide video interviews, procedures and general updates on the latest trends within the area, as well as featuring carefully selected video from our partners.

View Conference Highlights

András Illés, ESMO 2018 – A New Biosimilar for the Treatment of Chemotherapy-induced Neutropenia

Haematology

András Illés, ESMO 2018 – A New Biosimilar for the Treatment of Chemotherapy-induced Neutropenia

In an expert interview at ESMO 2018, Dr András Illés discusses the current research behind RGB-02, a biosimilar pegfilgrastim for…

Haematology

Maria Domenica Cappellini, ASH 2018 – Gaucher Disease for the Haematologist
Haematological Malignancies

Robin Foà, ASH 2018 – Developments in the Treatment of Haematological Malignancies
Multiple Myeloma

Constantine Mitsiades, ASH 2018 – Latest Developments in the Treatment of Multiple Myeloma

View All Videos

Articles

touchONCOLOGY publish two peer-reviewed, free-to-access journals specialising in the publication of topical review articles authored by leading experts in the field.

Gaucher Disease for the Haematologist

Maria-Domenica Cappellini

European Oncology & Haematology. 2019;15(1):Epub ahead of print

oncology Article
Large-scale Genomic Testing Facilitates Precision Medicine in Routine Cancer Care

Ricardo H Álvarez

Oncology & Hematology Review, 2018;15(1):Epub ahead of print

Diagnostics and Screening
Foreword – European Oncology & Haematology. 2018;14(2):75

Axel S Merseburger

European Oncology & Haematology. 2018;14(2):75

oncology Article
Targeted Alpha Therapy – Optimising Survival in Advanced Prostate Cancer

Johann S De Bono

European Oncology & Haematology. 2018;14(Suppl 3);3–10

Genitourinary Cancers

View All Articles

Insights

The following are quick, non peer-reviewed, opinion-based updates addressing current trends and opinion on the most recent advances in the area of oncology.

View All Insights

Society Partners

Quick Links

Other websites from

Touch Medical Media Limited, trading as Touch Medical Media, is a private limited company registered in England and Wales at The White House, Mill Road, Goring, Reading, England, RG8 9DD with registered number 08197142. © 2019 All rights reserved.

Touchoncology is for informational purposes and intended for healthcare professionals only. Its content should not be considered medical advice, diagnosis or treatment recommendations.